Literature DB >> 33070299

High-resolution functional connectivity of the default mode network in young adults with down syndrome.

Katherine A Koenig1, Lynn M Bekris2, Stephen Ruedrich3, Grace E Weber2, Maria Khrestian2, Se-Hong Oh4,5, Sanghoon Kim4, Z Irene Wang6, James B Leverenz7.   

Abstract

Studies of resting-state functional connectivity MRI in Alzheimer's disease suggest that disease stage plays a role in functional changes of the default mode network. Individuals with the genetic disorder Down syndrome show an increased incidence of early-onset Alzheimer's-type dementia, along with early and nearly universal neuropathologic changes of Alzheimer's disease. The present study examined high-resolution functional connectivity of the default mode network in 11 young adults with Down syndrome that showed no measurable symptoms of dementia and 11 age- and sex-matched neurotypical controls. We focused on within-network connectivity of the default mode network, measured from both anterior and posterior aspects of the cingulate cortex. Sixty-eight percent of connections to the posterior cingulate and 26% to the anterior cingulate showed reduced strength in the group with Down syndrome (p < 0.01). The Down syndrome group showed increased connectivity strength from the anterior cingulate to the bilateral inferior frontal gyri and right putamen (p < 0.005). In an exploratory analysis, connectivity in the group with Down syndrome showed regional relationships to plasma measures of inflammatory markers and t-tau. In non-demented adults with Down syndrome, functional connectivity within the default mode network may be analogous to changes reported in preclinical Alzheimer's disease, and warrants further investigation as a measure of dementia risk.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Default mode network; Dementia; Down syndrome; Functional MRI

Mesh:

Year:  2020        PMID: 33070299      PMCID: PMC8053201          DOI: 10.1007/s11682-020-00399-z

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.224


  51 in total

1.  Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations.

Authors:  M J Lowe; B J Mock; J A Sorenson
Journal:  Neuroimage       Date:  1998-02       Impact factor: 6.556

2.  Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome.

Authors:  F E Visser; A P Aldenkamp; A C van Huffelen; M Kuilman; J Overweg; J van Wijk
Journal:  Am J Ment Retard       Date:  1997-01

3.  Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.

Authors:  Marwan N Sabbagh; Kewei Chen; Joseph Rogers; Adam S Fleisher; Carolyn Liebsack; Dan Bandy; Christine Belden; Hillary Protas; Pradeep Thiyyagura; Xiaofen Liu; Auttawut Roontiva; Ji Luo; Sandra Jacobson; Michael Malek-Ahmadi; Jessica Powell; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

4.  PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).

Authors:  Michael S Rafii; Ana S Lukic; Randolph D Andrews; James Brewer; Robert A Rissman; Stephen C Strother; Miles N Wernick; Craig Pennington; William C Mobley; Seth Ness; Dawn C Matthews
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome.

Authors:  J P Kesslak; S F Nagata; I Lott; O Nalcioglu
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

6.  Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.

Authors:  Min Shi; Joshua Bradner; Aneeka M Hancock; Kathryn A Chung; Joseph F Quinn; Elaine R Peskind; Douglas Galasko; Joseph Jankovic; Cyrus P Zabetian; Hojoong M Kim; James B Leverenz; Thomas J Montine; Carmen Ginghina; Un Jung Kang; Kevin C Cain; Yu Wang; Jan Aasly; David Goldstein; Jing Zhang
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422

7.  Alzheimer's disease and Down's syndrome: an in vivo MRI study.

Authors:  F Beacher; E Daly; A Simmons; V Prasher; R Morris; C Robinson; S Lovestone; K Murphy; D G M Murphy
Journal:  Psychol Med       Date:  2008-07-30       Impact factor: 7.723

8.  SimPACE: generating simulated motion corrupted BOLD data with synthetic-navigated acquisition for the development and evaluation of SLOMOCO: a new, highly effective slicewise motion correction.

Authors:  Erik B Beall; Mark J Lowe
Journal:  Neuroimage       Date:  2014-06-24       Impact factor: 6.556

9.  The influence of head motion on intrinsic functional connectivity MRI.

Authors:  Koene R A Van Dijk; Mert R Sabuncu; Randy L Buckner
Journal:  Neuroimage       Date:  2011-07-23       Impact factor: 6.556

10.  Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.

Authors:  Kelly D Sullivan; Donald Evans; Ahwan Pandey; Thomas H Hraha; Keith P Smith; Neil Markham; Angela L Rachubinski; Kristine Wolter-Warmerdam; Francis Hickey; Joaquin M Espinosa; Thomas Blumenthal
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

View more
  3 in total

1.  Youth with Down syndrome display widespread increased functional connectivity during rest.

Authors:  Kelsey D Csumitta; Stephen J Gotts; Liv S Clasen; Alex Martin; Nancy Raitano Lee
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

2.  Altered spontaneous brain activity in Down syndrome and its relation with cognitive outcome.

Authors:  Cristina Cañete-Massé; Maria Carbó-Carreté; Maribel Peró-Cebollero; Shi-Xian Cui; Chao-Gan Yan; Joan Guàrdia-Olmos
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

3.  Abnormal degree centrality and functional connectivity in Down syndrome: A resting-state fMRI study.

Authors:  Cristina Cañete-Massé; Maria Carbó-Carreté; Maribel Peró-Cebollero; Shi-Xian Cui; Chao-Gan Yan; Joan Guàrdia-Olmos
Journal:  Int J Clin Health Psychol       Date:  2022-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.